JPL Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.45M Sell
25,639
-1,249
-5% -$269K 1.28% 24
2026
Q1
$5.85M Buy
26,888
+90
+0.3% +$20K 1.35% 25
2025
Q4
$6.12M Sell
26,798
-1,546
-5% -$352K 1.49% 20
2025
Q3
$6.56M Buy
28,344
+679
+2% +$138K 1.56% 13
2025
Q2
$5.14M Buy
27,665
+628
+2% +$117K 1.39% 21
2025
Q1
$5.66M Buy
27,037
+1,084
+4% +$211K 1.62% 12
2024
Q4
$4.61M Buy
+25,953
New +$4.77M 1.32% 20
2024
Q2
$3.26M Buy
18,999
+1,133
+6% +$188K 1.6% 18
2024
Q1
$3.25M Buy
17,866
+2,153
+14% +$371K 1.8% 11
2023
Q4
$2.44M Buy
+15,713
New +$2.29M 1.75% 15

Other funds holding ABBV

JPL Wealth Management's ABBV Position: Q2 2026 in Review

JPL Wealth Management reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $269K and leaving 25,639 shares worth $6.45M. The position accounts for 1.28% of the portfolio, ranked #24.

JPL Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.56M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JPL Wealth Management held 25,639 shares of AbbVie worth $6.45M as of Q2 2026.
  • JPL Wealth Management sold 1,249 AbbVie shares in Q2 2026, an estimated $269K.
  • AbbVie made up 1.28% of JPL Wealth Management's portfolio in Q2 2026, its #24 holding.
  • JPL Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • JPL Wealth Management's AbbVie position peaked at $6.56M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.